Inhibition of TRPM2 channels may offer a therapeutic strategy for treating endothelial dysfunction associated with oxidative stress, as TRPM2-activated Ca2+ signaling is necessary for inducing endothelial insulin resistance in obesity (208). The gene discussed is TRPM2; the disease is obesity disorder.